Turkish Validity and Reliability Study of Hospital for Special Surgery Shoulder Surgery Expectations Survey
Launched by GAZI UNIVERSITY · Aug 10, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a survey that helps understand what patients expect from shoulder surgery, specifically for those who speak Turkish. The goal is to make sure that this survey works well for Turkish-speaking patients by translating it and testing it with individuals who have had shoulder surgery. Researchers want to ensure that the survey accurately reflects patients' expectations and is reliable for use in Turkey.
To be eligible for this study, participants must be adults aged 18 and older who have had shoulder surgery and are native Turkish speakers. The trial is currently not recruiting participants, but once it starts, those who join will help improve a tool that can better support future patients. Participants will complete the survey and, through this process, contribute to making healthcare more accessible and effective for Turkish-speaking individuals facing shoulder surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Underwent Shoulder Surgery
- • Native Turkish Speakers
- • Adults (18 years and older)
- • Consent to Participate
- Exclusion Criteria:
- • -
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Ulunay Kanatlı, Professor
Study Director
Gazi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported